Yonghe as the CDMO partner will provide production process development and cGMP manufacturing services for Ablaze
The focus of the companies in this partnership is to synergise capabilities, leverage research and bring innovative products in specific therapeutic areas
GlobalData’s ‘Pharmaceutical Intelligence Center’ observes that India is still in the nascent stage of developing these potential therapies as currently only four cell/gene therapy molecules are being developed in the country.
During the research term, Olema will contribute funding to Aurigene to facilitate ongoing discovery efforts.
Construction will begin in early 2023, and the plant is scheduled to go onstream in 2025
Experts will speak about primary tumours of the nervous system and also the tumours of other body parts which get metastasized to the nervous system
The collaboration will leverage EdiGene’s expertise in high-throughput genome editing screening and Neukio’s strength in the development and manufacturing of induced pluripotent stem cell (iPSC) and natural killer cell (NK Cell)
Fast, flexible space allows clinical trials to start when needed. A trial can become operational, pivot or scale without traditional capital building expenditures
Entos will receive an initial payment of US $50 million, which includes an equity investment by Lilly
The ground-breaking project, led by Genomics England and NHS England, was established in 2013 to sequence 100,000 whole genomes from NHS patients and their families
Subscribe To Our Newsletter & Stay Updated
